Leaderboards/Testicular diseases and treatments

Testicular diseases and treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Ani Chi
South China University of Technology
2
Markus Angerer
Asklepios Klinik Altona
3
Osman M. Osman
Al Fashir University
4
Tat-Chuan Cham
University of Saskatchewan
5
Rand Ajaj
University of Toronto
6
Nuphat Yodkhunnatham
University of California San Diego
7
Nasreen Abdul Aziz
St Bartholomew's Hospital
8
Ayda Roudi Rasht Abadi
Kharazmi University
9
Noe Mbengue
Heidelberg University
10
Weisheng Yang
Jingdezhen University

Papers

1
Stem Leydig cells support macrophage immunological homeostasis through mitochondrial transfer in mice
Nature Communications|2024
49 cit.
2
An in vitro testicular organoid model for the study of testis morphogenesis, somatic cell maturation, endocrine function, and toxicological assessment of endocrine disruptors
Reproductive Toxicology|2024
17 cit.
3
Reconstructing the Stem Leydig Cell Niche via the Testicular Extracellular Matrix for the Treatment of Testicular Leydig Cell Dysfunction
Advanced Science|2024
11 cit.
4
Publication in Oncology (2024) [9 citations, W4396698683]
Oncology|2024
9 cit.
5
Publication in Cancers (2025) [8 citations, W4409813688]
Cancers|2025
8 cit.
6
Publication in Urologia Internationalis (2025) [5 citations, W4406141783]
Urologia Internationalis|2025
5 cit.
7
Publication in Cancers (2025) [4 citations, W4409895941]
Cancers|2025
4 cit.
8
Publication in Die Urologie (2025) [1 citation, W4414168484]
Die Urologie|2025
1 cit.
9
Publication in BJUI Compass (2026) [1 citation, W7123339330]
BJUI Compass|2026
1 cit.
10
Publication in European Urology Open Science (2024) [W4402442719]
European Urology Open Science|2024
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ad Gillis
Princess Máxima Center
2
J. Todd Auman
University of North Carolina at Chapel Hill
3
Kyle R. Covington
Duke University
4
Lenora A. Pluchino
National Comprehensive Cancer Network
5
Majid Shokoohi
Tabriz University of Medical Sciences
6
Nabil Adra
Indiana University Health
7
Brian Hu
Riverside University Health System - Medical Center
8
İmran İnce
Tokat Gaziosmanpaşa Üniversitesi
9
Małgorzata Kotula‐Balak
University of Agriculture in Krakow
10
Jamie Magrill
McGill University

Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
3
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
Journal of Clinical Oncology|2023
103 cit.
4
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.
5
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Investigational New Drugs|2022
47 cit.
6
Different types of bisphenols alter ovarian steroidogenesis: Special attention to BPA
Heliyon|2023
43 cit.
7
Minocycline can reduce testicular apoptosis related to varicocele in male rats
Andrologia|2022
41 cit.
8
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
PubMed|2022
32 cit.
9
The Effects of Clove Oil on The Biochemical and Histological Parameters, and Autophagy Markers in Polycystic Ovary Syndrome-Model Rats.
PubMed|2023
30 cit.
10
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022
Journal of the National Comprehensive Cancer Network|2023
19 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
John P. Donohue
University of Nevada, Las Vegas
2
Lawrence H. Einhorn
Indiana University Health
3
Niels E. Skakkebæk
Copenhagen University Hospital
4
Leendert H. J. Looijenga
University Medical Center Utrecht
5
Robert E. Scully
Ollscoil na Gaillimhe – University of Galway
6
Joel Sheinfeld
Memorial Sloan Kettering Cancer Center
7
Ieuan A. Hughes
University of Cambridge
8
Carsten Bokemeyer
Universität Hamburg
9
Robert J. Motzer
Memorial Sloan Kettering Cancer Center
10
Patrick J. Loehrer
Indiana Cancer Consortium

Papers

1
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine|2015
5.9k cit.
2
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
New England Journal of Medicine|2007
5.8k cit.
3
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine|2018
4.6k cit.
4
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
New England Journal of Medicine|2007
3.6k cit.
5
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
The Lancet|2008
3k cit.
6
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine|2019
2.5k cit.
7
Consensus Statement on Management of Intersex Disorders
PEDIATRICS|2006
2.3k cit.
8
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology|2009
2.2k cit.
9
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
New England Journal of Medicine|2013
1.9k cit.
10
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?
The Lancet|1993
1.9k cit.

Reagents for Testicular diseases and treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

#A4502
View Evidence →
Agilent/Dako

D2-40

#M3619
View Evidence →
Agilent/DakoEvidence 60

EnVision FLEX /HRP

#SM802
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 62

TPBG/5T4 (E4T8Q) Rabbit Monoclonal Antibody

Cited in 5 papers
#30874$194,431
View Evidence →
Agilent/Dako

Placental Alkaline Phosphatase

Cited in 5 papers
#M7191
View Evidence →
Agilent/Dako

Alpha-1-Fetoprotein Pathology Antibody

#A0008
View Evidence →